Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study. [electronic resource]
Producer: 20140204Description: 982-7 p. digitalISSN:- 1476-5365
- Acute Disease
- Adolescent
- Adult
- Age Factors
- Alemtuzumab
- Allografts
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Disease-Free Survival
- Female
- Graft vs Host Disease -- etiology
- Graft vs Leukemia Effect
- Humans
- Male
- Middle Aged
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- mortality
- Sex Factors
- Societies, Medical
- Stem Cell Transplantation
- Survival Rate
- Transplantation Conditioning
- United Kingdom
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.